Bayer to invest EUR 220 million in new R&D facility at its Monheim site
Bayer significantly strengthens its commitment to innovation in regenerative agriculture with a EUR 220 million investment in research and development (R&D) at its Monheim site. This is the company’s largest single investment in its Crop Protection business in Germany since the founding of the Monheim campus in ...
Nordrhein Westfalen Rachel Rama Dirk Backhaus Robert Reiter Axel Trautwein Bayer Crop Science Division
Source: pharmiweb.com